Radiopharm Theranostics Limited published two announcements to the Australian Securities Exchange on June 30, 2026, regarding the cessation of securities and unquoted securities. The filing serves as a notification of these changes to the ASX. Radiopharm Theranostics Limited is a radiopharmaceutical company focused on theranostics development.
